References to EndoGrade® Endotoxin-free Ovalbumin

EndoGrade® Endotoxin-free Ovalbumin

EndoGrade® Endotoxin-free Ovalbumin Product Citations

EndoGrade® Ovalbumin is manufactured by LIONEX GmbH in Germany and distributed by Ilex Life Sciences LLC. This product has a guaranteed endotoxin (LPS) level below 0.1 EU/mg.

EndoGrade® Ovalbumin has been widely referenced in scientific literature. Below you will find some of the published scientific papers that reference EndoGrade® Ovalbumin:


Koutník, Jiří et al. “T cell-intrinsic protein kinase D3 is dispensable for the cells’ activation.” Frontiers in Immunology vol. 13 1049033. 17 Nov. 2022, doi:10.3389/fimmu.2022.1049033

Raaijmakers, Tonke K et al. “NSAIDs affect dendritic cell cytokine production.” PloS one vol. 17,10 e0275906. 13 Oct. 2022, doi:10.1371/journal.pone.0275906

Tang, Xin-Zi et al. “Bronchus-associated macrophages efficiently capture and present soluble inhaled antigens and are capable of local Th2 cell activation.” eLife vol. 11 e63296. 29 Sep. 2022, doi:10.7554/eLife.63296

Gros, Marine et al. “Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol during antigen cross-presentation.” Cell reports vol. 40,7 (2022): 111205. doi:10.1016/j.celrep.2022.111205

Martín-Otal, Celia et al. “Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells.” Journal for immunotherapy of cancer vol. 10,8 (2022): e004479. doi:10.1136/jitc-2021-004479

Balneger, N et al. “Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions.” Cellular and molecular life sciences : CMLS vol. 79,2 98. 28 Jan. 2022, doi:10.1007/s00018-021-04027-x


Abusarah, Jamilah et al. “Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice.” Cell reports. Medicine vol. 2,12 100455. 21 Dec. 2021, doi:10.1016/j.xcrm.2021.100455

Stoff, Melanie et al. “C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection.” Scientific reports vol. 11,1 23819. 10 Dec. 2021, doi:10.1038/s41598-021-03201-2

Weiden, Jorieke et al. “Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots.” ACS biomaterials science & engineering vol. 7,12 (2021): 5622-5632. doi:10.1021/acsbiomaterials.0c01648

Vollmann, Elisabeth H et al. “Specialized transendothelial dendritic cells mediate thymic T-cell selection against blood-borne macromolecules.” Nature communications vol. 12,1 6230. 28 Oct. 2021, doi:10.1038/s41467-021-26446-x

Caudill, Cassie et al. “Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity.” Proceedings of the National Academy of Sciences of the United States of America vol. 118,39 (2021): e2102595118. doi:10.1073/pnas.2102595118

Pavasutthipaisit, Suvarin et al. “CARD9 Deficiency Increases Hippocampal Injury Following Acute Neurotropic Picornavirus Infection but Does Not Affect Pathogen Elimination.” International journal of molecular sciences vol. 22,13 6982. 29 Jun. 2021, doi:10.3390/ijms22136982

Thomann, Anna Sophie et al. “Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo.” Frontiers in immunology vol. 12 704578. 25 Jun. 2021, doi:10.3389/fimmu.2021.704578

Clemen, Ramona et al. “Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice.” Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 8,10 2003395. 8 Mar. 2021, doi:10.1002/advs.202003395

Tadayon, Sina et al. “Lymphatic Endothelial Cell Activation and Dendritic Cell Transmigration Is Modified by Genetic Deletion of Clever-1.” Frontiers in immunology vol. 12 602122. 4 Mar. 2021, doi:10.3389/fimmu.2021.602122

Prado Acosta, Mariano et al. “S-Layer From Lactobacillus brevis Modulates Antigen-Presenting Cell Functions via the Mincle-Syk-Card9 Axis.” Frontiers in immunology vol. 12 602067. 1 Mar. 2021, doi:10.3389/fimmu.2021.602067

Lirussi, Darío et al. “Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal Vaccines.” Pharmaceutics vol. 13,2 188. 1 Feb. 2021, doi:10.3390/pharmaceutics13020188


Silva, Leyre et al. “Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma.” Cancers vol. 12,11 3397. 16 Nov. 2020, doi:10.3390/cancers12113397

Xu, Dan Dan et al. “Akt+ IKKα/β+ Rab5+ Signalosome Mediate the Endosomal Recruitment of Sec61 and Contribute to Cross-Presentation in Bone Marrow Precursor Cells.” Vaccines vol. 8,3 539. 17 Sep. 2020, doi:10.3390/vaccines8030539

Kim, Eui Ho et al. “Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway.” eLife vol. 9 e52687. 9 Jun. 2020, doi:10.7554/eLife.52687

Raaijmakers, Tonke K et al. “Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes.” Journal for immunotherapy of cancer vol. 8,1 (2020): e000649. doi:10.1136/jitc-2020-000649

Abdissa, Ketema et al. “Relevance of inducible nitric oxide synthase for immune control of Mycobacterium avium subspecies paratuberculosis infection in mice.” Virulence vol. 11,1 (2020): 465-481. doi:10.1080/21505594.2020.1763055

Baumann, Daniel et al. “Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy.” Nature communications vol. 11,1 2176. 1 May. 2020, doi:10.1038/s41467-020-15979-2

Miura, Risako et al. “Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody.” RSC advances vol. 10,14 8074-8079. 25 Feb. 2020, doi:10.1039/c9ra10066k

Schmitz, Katja et al. “Progranulin deficiency confers resistance to autoimmune encephalomyelitis in mice.” Cellular & molecular immunology vol. 17,10 (2020): 1077-1091. doi:10.1038/s41423-019-0274-5


Raulf, Marie-Kristin et al. “The C-type Lectin Receptor CLEC12A Recognizes Plasmodial Hemozoin and Contributes to Cerebral Malaria Development.” Cell reports vol. 28,1 (2019): 30-38.e5. doi:10.1016/j.celrep.2019.06.015

Hyde, Evelyn J et al. “Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols.” BMC immunology vol. 20,1 18. 4 Jun. 2019, doi:10.1186/s12865-019-0295-y

Castro-Dopico, Tomas et al. “Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis.” Immunity vol. 50,4 (2019): 1099-1114.e10. doi:10.1016/j.immuni.2019.02.006

Wculek, Stefanie K et al. “Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.” Journal for immunotherapy of cancer vol. 7,1 100. 8 Apr. 2019, doi:10.1186/s40425-019-0565-5

Ilex Life Sciences is an authorized distributor of LIONEX GmbH.